Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, USA.
Psychiatr Danub. 2019 Sep;31(3):290-307. doi: 10.24869/psyd.2019.290.
Temperament traits of Novelty Seeking, Harm Avoidance, Reward Dependence, and Persistence, are well defined in terms of their neural circuitry, neurochemical modulators, and patterns of associative learning. When heritably excessive, each of these traits may become a mechanistically fundamental biogenetic trait vulnerability for personality disorder. The other main risk factor for personality disorder is environmental, notably abuse, neglect, and psychological trauma. The emerging concept of mechanism-based pharmacotherapy aims to activate the brain's homeostasis as the only available delivery system to re-calibrate complex neurophysiological participants in each of the temperament traits. In a positive feedback, a homeostasis-driven improvement of excessive temperament is expected to facilitate maturation of neocortical networks of cognition, most reliably in expert psychotherapy (Part I of this paper) and, ultimately, thereby improve top-down cortical control of subcortical affect reactivity. As an emerging concept informed by neuroscience and clinical research, mechanism-based pharmacotherapy has the potential to be superior to traditional symptom-based treatments. Such mechanism-based approach illustrates what the pharmacological treatment of Research Domain Criteria (RDoC) might look like.
在神经回路、神经化学调质和联想学习模式方面,新颖寻求、回避伤害、奖励依赖和坚持特质都有明确的特征。如果这些特质具有遗传性过度,那么每一种特质都可能成为人格障碍的一种机械上根本的生物遗传易感性脆弱性。人格障碍的另一个主要风险因素是环境,特别是虐待、忽视和心理创伤。基于机制的药物治疗的新概念旨在激活大脑的动态平衡,这是唯一可用的传递系统,以重新校准每个气质特质中复杂的神经生理参与者。在一个正反馈中,过度气质的动态平衡驱动的改善预计将促进新皮层认知网络的成熟,在专家心理治疗中最可靠(本文第一部分),最终从而改善皮质下情感反应的皮质自上而下控制。作为一个由神经科学和临床研究提供信息的新兴概念,基于机制的药物治疗有可能优于传统的基于症状的治疗。这种基于机制的方法说明了研究领域标准(RDoC)的药物治疗可能是什么样子。